TRI Workgroups

The workgroups represent seven research domains of interest. Each group has a detailed work program dedicated to a specific topic, on which researchers and clinicians from different disciplines actively collaborate. They assemble expertise and knowledge, cover the state of the art and assure effective synergy between different projects. Membership and program are constantly updated. Interested people are invited to contact the workgroup leader directly.

Ana Belén Elgoyhen, Buenos Aires, Argentina
The aim of this workgroup is the development of drug treatments for tinnitus. Both animal studies and clinical trials will be performed in order to discover the potential of specific compounds to alleviate or abolish different forms of subjective tinnitus.
Principal Investigators of the TRI Pharmagroup:
Clinical Trials

Animal Studies
read more ...

Dirk De Ridder, Otago, New Zealand
This workgroup aims to develop more efficient neurostimulation strategies for the treatment of tinnitus. It also focuses on a more detailed understanding of the pathophysiology of tinnitus by visualization of tinnitus-related changes in the brain, in as much as this is necessary to improve efficacy of stimulation designs.
read more ...

Grant Searchfield, Auckland, New Zealand
Specific auditory training procedures are developed, which might result in permanent tinnitus reduction by inducing learning-related plasticity.
Luca del Bo, Milan, Italy
Reduction in tinnitus may also occur through passive auditory stimulation, by exposing patients to specific auditory stimuli either through hearing aids or sound generators.

Tanit Ganz Sanchez, São Paulo, Brazil
This group aims to increase knowledge in somatosensory tinnitus, and develop new therapies by means of different forms of somatosensory modulation.
Arrowread more about "Somatosensory Tinnitus (from past to now)"

Manuela Mazzoli, Padova, Italy
This workgroup will systematically explore the therapeutic potential of specific diets, complementary nutriments and personalized prescriptions.

Michael Landgrebe, Germany
The objective is to set up a quality-controlled common database to be used by all tinnitus clinics and researchers in order to be able to compare data across centers and trials. By identifying subgroups that share specific characteristics and respond to similar treatments this workgroup targets the development of evidence-based individualized treatment algorithms.
external linkTinnitus Database Project

Berthold Langguth, Regensburg, Germany
Michel Paolino, Marseille, France
The established network of Tinnitus Clinics will contribute to research, develop new therapies and establish a guide of good practices. Several clinics based on different continents with different local specialities and specific areas of competence provide the basis for an expanding international and mutlidisciplinary network. TRI coordinates meetings for clinicians to share experiences, to discuss a common approach to patients, to agree on new outcomes and priorities, to coordinate multicenter research projects and to develop the best practices. For the moment a consensus for patient assessment and outcome measurements has been published and its utilisation is largely recommended.
First participating clinics are in
Antwerp, Belgium BRAI2N CLINIC AntwerpBRAI2N CLINIC Antwerp
Auckland, New Zealand The University of Auckland’s Hearing and Tinnitus ClinicThe University of Auckland’s Hearing and Tinnitus Clinic
Marseille, France Centre des acouphènes (IMERTA)Centre des acouphènes (IMERTA)
Milan, Italy
Regensburg, Germany Tinnituszentrum RegensburgTinnituszentrum Regensburg
São Paulo, Brazil
and Valencia, Spain